253 related articles for article (PubMed ID: 15668295)
1. Catalytically inactive human cathepsin D triggers fibroblast invasive growth.
Laurent-Matha V; Maruani-Herrmann S; Prébois C; Beaujouin M; Glondu M; Noël A; Alvarez-Gonzalez ML; Blacher S; Coopman P; Baghdiguian S; Gilles C; Loncarek J; Freiss G; Vignon F; Liaudet-Coopman E
J Cell Biol; 2005 Jan; 168(3):489-99. PubMed ID: 15668295
[TBL] [Abstract][Full Text] [Related]
2. The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration.
Etscheid M; Beer N; Dodt J
Cell Signal; 2005 Dec; 17(12):1486-94. PubMed ID: 16153533
[TBL] [Abstract][Full Text] [Related]
3. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis.
Liaudet-Coopman E; Beaujouin M; Derocq D; Garcia M; Glondu-Lassis M; Laurent-Matha V; Prébois C; Rochefort H; Vignon F
Cancer Lett; 2006 Jun; 237(2):167-79. PubMed ID: 16046058
[TBL] [Abstract][Full Text] [Related]
5. Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.
Beaujouin M; Prébois C; Derocq D; Laurent-Matha V; Masson O; Pattingre S; Coopman P; Bettache N; Grossfield J; Hollingsworth RE; Zhang H; Yao Z; Hyman BT; van der Geer P; Smith GK; Liaudet-Coopman E
J Cell Sci; 2010 Oct; 123(Pt 19):3336-46. PubMed ID: 20826454
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?
Masson O; Bach AS; Derocq D; Prébois C; Laurent-Matha V; Pattingre S; Liaudet-Coopman E
Biochimie; 2010 Nov; 92(11):1635-43. PubMed ID: 20493920
[TBL] [Abstract][Full Text] [Related]
7. Biological and clinical significance of cathepsin D in breast cancer metastasis.
Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
[TBL] [Abstract][Full Text] [Related]
8. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
9. Role of enzymatically inactive procathepsin D in lung cancer.
Vetvicka V; Vetvickova J; Benes P
Anticancer Res; 2004; 24(5A):2739-43. PubMed ID: 15517880
[TBL] [Abstract][Full Text] [Related]
10. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.
Capony F; Rougeot C; Montcourrier P; Cavailles V; Salazar G; Rochefort H
Cancer Res; 1989 Jul; 49(14):3904-9. PubMed ID: 2736531
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.
Derocq D; Prébois C; Beaujouin M; Laurent-Matha V; Pattingre S; Smith GK; Liaudet-Coopman E
Oncogene; 2012 Jun; 31(26):3202-12. PubMed ID: 22081071
[TBL] [Abstract][Full Text] [Related]
12. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors.
Liaudet E; Derocq D; Rochefort H; Garcia M
Cell Growth Differ; 1995 Sep; 6(9):1045-52. PubMed ID: 8519680
[TBL] [Abstract][Full Text] [Related]
13. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cytokines increase extracellular procathepsin D in permanent and primary endothelial cell cultures.
Erdmann S; Ricken A; Hummitzsch K; Merkwitz C; Schliebe N; Gaunitz F; Strotmann R; Spanel-Borowski K
Eur J Cell Biol; 2008 May; 87(5):311-23. PubMed ID: 18387691
[TBL] [Abstract][Full Text] [Related]
15. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.
Briozzo P; Morisset M; Capony F; Rougeot C; Rochefort H
Cancer Res; 1988 Jul; 48(13):3688-92. PubMed ID: 3378211
[TBL] [Abstract][Full Text] [Related]
16. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
Bessard A; Frémin C; Ezan F; Fautrel A; Gailhouste L; Baffet G
Oncogene; 2008 Sep; 27(40):5315-25. PubMed ID: 18521085
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis.
Berchem G; Glondu M; Gleizes M; Brouillet JP; Vignon F; Garcia M; Liaudet-Coopman E
Oncogene; 2002 Aug; 21(38):5951-5. PubMed ID: 12185597
[TBL] [Abstract][Full Text] [Related]
19. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
[TBL] [Abstract][Full Text] [Related]
20. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
